Sandoz Conducting Voluntary Recall

Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer.

To learn more visit,


Leave a Reply

Your email address will not be published.


Health Alerts

Get new posts by email:
Follow by Email77.5k